Glaukos Corporation Glaukos Corporation

Glaukos Corporation

GKOS

Classificação em ações #1966
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Preço da ação
$177.09
Última sincronização: 2026-10-21
Valor de mercado
$10.45B
Variação (1 dia)
1.76%
Variação (1 ano)
131.10%
País
US
Negociar Glaukos Corporation (GKOS)

Categoria

Healthcare
Histórico de preços das ações de Glaukos Corporation (GKOS)
Preço de fecho mais alto: $166.80 em 2026-10-01

Preço de fecho mais baixo: $29.05 em 2015-06-01
Histórico de preços das ações da Glaukos Corporation de 2015 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 16.37%
2025 -22.38%
2024 97.91%
2023 64.84%
2022 1.09%
2021 -38.87%
2020 24.29%
2019 -5.51%
2018 133.10%
2017 -22.73%
2016 38.93%
2015 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$100.56 -21.41%
US
$93.07 -2.95%
IE
$297.13 -23.49%
US
$44.47 -57.18%
US
$46.69 -18.50%
DE